Apr 29, 2026 06:45AM
Apr 29, 2026 06:45AM
Apr 28, 2026 08:35AM
Apr 7, 2026 12:05PM
Apr 7, 2026 12:05PM
Mar 9, 2026 08:07AM
Feb 5, 2026 04:02PM Coeptis receives shareholder approval for Z Squared merger
Feb 5, 2026 04:00PM
Feb 4, 2026 04:15AM
Jan 6, 2026 08:33AM
Jan 6, 2026 08:31AM
Sep 23, 2025 08:00AM
Jun 26, 2025 08:34AM
May 12, 2025 08:20AM Nuburu (BURU) Files $100M SEC Registration Statement
May 12, 2025 08:20AM
Apr 28, 2025 01:35PM
Apr 25, 2025 08:38AM
Apr 17, 2025 08:39AM
Apr 17, 2025 08:38AM
Apr 15, 2025 08:33AM
Apr 15, 2025 08:33AM NUBURU Announces Strategic Corporate Update Focused on Defense & Security, Advanced Technologies, and Growth Initiatives
Mar 6, 2025 08:00AM
Feb 13, 2025 08:39AM
Feb 13, 2025 08:39AM
Feb 6, 2025 08:08AM
Jan 30, 2025 08:27AM
Jan 30, 2025 08:27AM
Dec 26, 2024 08:16AM Coeptis Therapeutics (COEP) Acquires NexGenAI Affiliates Network, Launches Coeptis Technologies
Dec 26, 2024 08:15AM
Dec 12, 2024 08:01AM
Dec 12, 2024 08:00AM
Dec 3, 2024 08:16AM
Dec 3, 2024 08:15AM
Oct 11, 2023 07:31AM
Oct 11, 2023 07:30AM Coeptis Therapeutics Expands License Agreement with University of Pittsburgh to Include SNAP-CAR NK Cell Technology
Sep 22, 2023 07:05AM
Apr 18, 2023 07:32AM
Apr 18, 2023 07:30AM
Mar 29, 2023 09:45AM
Mar 29, 2023 09:45AM
Nov 2, 2022 07:02AM
Nov 2, 2022 07:00AM Coeptis Therapeutics Holdings Expands Board of Directors with New Appointments
May 17, 2022 07:00AM
Apr 19, 2022 07:00AM
Apr 13, 2022 04:06PM
Apr 13, 2022 04:05PM
Apr 13, 2022 07:01AM
Apr 13, 2022 07:00AM
Aug 19, 2021 08:30AM Coeptis Therapeutics Partners with VyGen-Bio, Inc. to Co-develop Two Assets Designed to Improve the Treatment of CD38-Related Cancers

1,155,357 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All